TP53-Mutated Myelodysplastic Syndrome and Acute Myeloid Leukemia: Biology, Current Therapy, and Future Directions. (2022)

First Author: Daver NG
Attributed to:  Biology and Treatment of Human Myeloid Cancers funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/2159-8290.cd-22-0332

PubMed Identifier: 36218325

Publication URI: http://europepmc.org/abstract/MED/36218325

Type: Journal Article/Review

Volume: 12

Parent Publication: Cancer discovery

Issue: 11

ISSN: 2159-8274